Mergers & Acquisitions
Jan. 11, 2006
Deals
LOS ANGELES - CancerVax, Micromet Agree to Join Forces Biotechnology companies CancerVax Corp. and Micromet AG have announced plans to merge, creating a trans-Atlantic, Nasdaq-listed company with a drug development pipeline focused on oncology, autoimmune and inflammatory diseases.
CancerVax, Micromet
Agree to Join Forces
Biotechnology companies CancerVax Corp. and Micromet AG have announced plans to merge, creating a trans-Atlantic, Nasdaq-listed company with a drug development ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In